EXPERT ADVISORS. EXACT PRACTICES.
Dead / Cancelled — Cancelled — Section 8 (as of 26 Jan 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85776260
- Registration number
- 4367732
- Mark type
- Stylized text
- Filed
- 09 Nov 2012
- Published for opposition
- 30 Apr 2013
- Registered
- 16 Jul 2013
- Attorney of record
- Joshua G. Gigger
Goods and services
- Class 035 — Advertising and business services: Identification of regulatory strategies for product market applications and reimbursement; preparation and submission of product applications to the FDA and other regulatory agencies; preparing business reports for governmental agencies and medical journals resulting from clinical studies; providing reimbursement and health economic services, namely, researching and analyzing current reimbursement policies, product and procedure codes and pricing; providing due diligence services, namely, evaluating regulatory strategies, clinical strategies, product reimbursement strategies and quality systems on behalf of venture capitalists
- Class 042 — Scientific and technological services: Contract regulatory and clinical services, namely, strategy development in the nature of consulting services regarding scientific and technical aspects of clinical trials and submissions to the FDA and other regulatory agencies; designing, implementing and managing clinical trials for product testing and development purposes; developing and managing clinical studies, clinical protocol, data management and analysis for clinical trials; preparing scientific reports resulting from clinical studies; developing and managing regulatory quality systems and compliance matters for medical product manufacturers; designing and implementing pre-clinical research services, namely, scientific animal research; preparing scientific reports as to results of studies for governmental agencies and medical journals resulting from clinical studies; designing animal medical experiments; designing, implementing and analyzing human clinical studies, namely, protocol development, site initiation, database development and management and data analysis
Owner
- Regulatory & Clinical Research Institute, Inc., Minneapolis, MN, US
- Regulatory & Clinical Research Institute, Inc., Minneapolis, MN, US
- Regulatory & Clinical Research Institute, Inc., Minneapolis, MN, US
Prosecution history
- 26 Jan 2024 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 16 Jul 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 02 May 2019 — CORRECTION UNDER SECTION 7 - PROCESSED
- 24 Apr 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Mar 2019 — TEAS SECTION 7 REQUEST RECEIVED
- 06 Sept 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Sept 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Sept 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Aug 2018 — TEAS SECTION 8 & 15 RECEIVED
- 16 Jul 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 Jul 2013 — REGISTERED-PRINCIPAL REGISTER
- 30 Apr 2013 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Apr 2013 — PUBLISHED FOR OPPOSITION
- 10 Apr 2013 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Mar 2013 — LAW OFFICE PUBLICATION REVIEW COMPLETED